CB2: a cannabinoid receptor with an identity crisis

被引：441
|
作者：
Atwood, Brady K. [1 ,2 ,3 ]
Mackie, Ken [1 ,2 ]
机构：
[1] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA
[2] Indiana Univ, Gill Ctr, Bloomington, IN 47405 USA
[3] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2010年 / 160卷 / 03期
关键词：
GPCR tissue distribution; microglia; sensory neurons; pain; immunocytochemistry; LIPOPOLYSACCHARIDE-TREATED RATS; TRABECULAR MESHWORK CELLS; CENTRAL-NERVOUS-SYSTEM; DORSAL-HORN NEURONS; PAIN MODELS; IN-VITRO; PHARMACOLOGICAL CHARACTERIZATION; NEUROPATHIC PAIN; INVERSE AGONIST; SENSORY NEURONS;
D O I：
10.1111/j.1476-5381.2010.00729.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
This article is part of a themed issue on Cannabinoids. To view the editorial for this themed issue visit http://dx.doi.org/10.1111/j.1476-5381.2010.00831.x.
引用
收藏
页码：467 / 479
页数：13
相关论文
共 50 条
  • [1] Cannabinoid Receptor CB2 Structure and CB2/Gi Signaling Mechanisms
    Xing, Changrui
    Zhang, Cheng
    Xie, Xiang-Qun
    [J]. FASEB JOURNAL, 2019, 33
  • [2] Brain Cannabinoid CB2 Receptor in Schizophrenia
    Ishiguro, Hiroki
    Horiuchi, Yasue
    Ishikawa, Maya
    Koga, Minori
    Imai, Keiko
    Suzuki, Yoshimi
    Morikawa, Miyuki
    Inada, Toshiya
    Watanabe, Yuichiro
    Takahashi, Makoto
    Someya, Toshiyuki
    Ujike, Hiroshi
    Iwata, Nakao
    Ozaki, Norio
    Onaivi, Emmanuel S.
    Kunugi, Hiroshi
    Sasaki, Tsukasa
    Itokawa, Masanari
    Arai, Makoto
    Niizato, Kazuhiro
    Iritani, Shyuji
    Naka, Izumi
    Ohashi, Jun
    Kakita, Akiyoshi
    Takahashi, Hitoshi
    Nawa, Hiroyuki
    Arinami, Tadao
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (10) : 974 - 982
  • [3] CB2 cannabinoid receptor mediation of antinociception
    Ibrahim, Mohab M.
    Rude, Megan L.
    Stagg, Nicola J.
    Mata, Heriberto P.
    Lai, Josephine
    Vanderah, Todd W.
    Porreca, Frank
    Buckley, Nancy E.
    Makriyannis, Alexandros
    Malan, T. Philip, Jr.
    [J]. PAIN, 2006, 122 (1-2) : 36 - 42
  • [4] Cannabichromene is a cannabinoid CB2 receptor agonist
    Udoh, Michael
    Santiago, Marina
    Devenish, Steven
    McGregor, Iain S.
    Connor, Mark
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (23) : 4537 - 4547
  • [5] Targeting the CB2 cannabinoid receptor in osteoporosis
    Bab, Itai
    Ofek, Orr
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (02) : 135 - 138
  • [6] Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands
    Poso, A.
    Huffman, J. W.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (02) : 335 - 346
  • [7] Cholesterol as a modulator of cannabinoid receptor CB2 signaling
    Yeliseev, Alexei
    Iyer, Malliga R.
    Joseph, Thomas T.
    Coffey, Nathan J.
    Cinar, Resat
    Zoubak, Lioudmila
    Kunos, George
    Gawrisch, Klaus
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Expression of CB2 cannabinoid receptor in Pichia pastoris
    Feng, W
    Cai, H
    Pierce, WM
    Song, ZH
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 2002, 26 (03) : 496 - 505
  • [9] The cannabinoid receptor CB2 is not associated with myocardial infarction
    Reinhard, W.
    Stark, K.
    Baessler, A.
    Fischer, M.
    Sedlacek, K.
    Hengstenberg, C.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 : 106 - 107
  • [10] Editorial: Therapeutic potential of the cannabinoid CB2 receptor
    Smoum, Reem
    Grether, Uwe
    Karsak, Meliha
    Vernall, Andrea J.
    Park, Frank
    Hillard, Cecilia J.
    Pacher, Pal
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
12345